| ²é¿´: 1174 | »Ø¸´: 4 | |||
zyf1986½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
¡¾×ªÌû¡¿ÊÀ½ç10´óÖØ°õÒ©,Æ·ÖÖ,³§¼Ò,ÏúÁ¿ºÍÊÊÓ¦Ö¢ ÒÑÓÐ4È˲ÎÓë
|
|
Lipitor Maker: Pfizer Sales Rank: 1 Technology: Chiral chemistry 2009 Sales: $12.5 billion Indications: Hypercholesterolemia and mixed dyslipidemia (Fredrickson types IIa and IIb) to reduce total cholesterol Á¢ÆÕÍ× Éú²úÉÌ£º»ÔÈð ÏúÊÛÅÅÃû£º1 ¼¼Êõ£ºÊÖÐÔÒ©Îï 2009ÄêÏúÊ۶125ÒÚÃÀÔª ÊÊÓ¦Ö¢£º½µÑªÖ¬£¬ÓÃÓڸߵ¨¹Ì´¼ÑªÖ¢ºÍ»ìºÏÐ͸ß֬Ѫ֢£¨Fredrickson IIa ºÍIibÐÍ£©¡£ Plavix Maker: Bristol-Myers Squibb and Sanofi-Aventis Sales Rank: 2 Technology: Small molecule 2009 Sales: $9.5 billion Indications: Heart attack and stroke prevention ²¨Á¢Î¬ Éú²úÉÌ£º°ÙʱÃÀÊ©¹ó±¦¼°Èüŵ·Æ°²ÍòÌØ ÏúÊÛÅÅÃû£º2 ¼¼Êõ£ºÐ¡·Ö×ÓÒ©Îï 2009ÄêÏúÊ۶95ÒÚÃÀÔª ÊÊÓ¦Ö¢£ºÓÃÓÚ·ÀÖÎÐ£ËÀ¼°ÄÔѪ˨¡£ Advair Maker: GlaxoSmithKline Sales Rank: 3 Technology: Small Molecule 2009 Sales: $7.7 billion Indications: Asthma and COPD Advair Éú²úÉÌ£º¸ðÀ¼ËØÊ·¿Ë ÏúÊÛÅÅÃû£º3 ¼¼Êõ£ºÐ¡·Ö×ÓÒ©Îï 2009ÄêÏúÊ۶77ÒÚÃÀÔª ÊÊÓ¦Ö¢£ºÏø´¼°ÂýÐÔ×èÈûÐÔ·ÎÆøÖ×£¨COPD£© Enbrel Maker: Amgen Sales Rank: 4 Technology: Recombinant product 2009 Sales: $6.2 billion Indications: Rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, chronic plaque psoriasis ¶÷Àû£¨ÒÀÄÇÎ÷ÆÕ£© Éú²úÉÌ£º°²½ø ÏúÊÛÅÅÃû£º4 ¼¼Êõ£ºÖØ×éÉúÎïÖÆ¼Á 2009ÄêÏúÊ۶62ÒÚÃÀÔª ÊÊÓ¦Ö¢£ºÓÃÓÚÀà·çʪ¹Ø½ÚÑס¢¹Ø½ÚÐÔţƤѢ¡¢Ó×ÄêÌØ·¢ÐԹؽÚÑס¢¹Ø½ÚǿӲÐÔ¼¹×µÑס¢ÂýÐÔ°ß¿éÐÍţƤѢ¡£ Diovan Maker: Novartis Sales Rank: 5 Technology: Small Molecule 2009 Sales: $6.0 billion Indications: Hypertension and congestive heart failure ´úÎÄ£¨çÓɳ̹£© Éú²úÉÌ£ºÅµ»ª ÏúÊÛÅÅÃû£º5 ¼¼Êõ£ºÐ¡·Ö×ÓÒ©Îï 2009ÄêÏúÊ۶60ÒÚÃÀÔª ÊÊÓ¦Ö¢£º¸ßѪѹ¼°³äѪÐÔÐÄÁ¦Ë¥½ß Remicade Maker: Johnson & Johnson Sales Rank: 6 Technology: Monoclonal antibody 2009 Sales: $5.9 billion Indications: Plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, Crohn's disease in adults, pediatric Crohn's disease, ulcerative colitis, and ankylosing spondylitis Remicade£¨¿¹Ö×Áö»µËÀÒò×Óµ¥¿Ë¡¿¹Ì壩 Éú²úÉÌ£ºÇ¿Éú ÏúÊÛÅÅÃû£º6 ¼¼Êõ£ºµ¥¿Ë¡¿¹Ìå 2009ÄêÏúÊ۶59ÒÚÃÀÔª ÊÊÓ¦Ö¢£º°ß¿é״ţƤѢ¡¢·çʪÐԹؽÚÑס¢ÒøÐ¼²¡¹Ø½ÚÑס¢³ÉÈË¿ËÂÞ¶÷²¡¡¢¶ùͯ¿ËÂÞ¶÷²¡¡¢À£ÑñÐԽ᳦Ñס¢¹Ø½ÚǿӲÐÔ¼¹×µÑ× Avastin Maker: Roche/Genentech Sales Rank: 7 Technology: Monoclonal antibody 2009 Sales: $5.7 billion Indications: Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, Metastatic Breast Cancer, Glioblastoma, Metastatic Kidney Cancer °¢Íß˹͡ Éú²úÉÌ£ºÂÞÊÏ/»ùÒòÌ©¿Ë ÏúÊÛÅÅÃû£º7 ¼¼Êõ£ºµ¥¿Ë¡¿¹Ìå 2009ÄêÏúÊ۶57ÒÚÃÀÔª ÊÊÓ¦Ö¢£º×ªÒÆÐÔ½áÖ±³¦°©¡¢·ÇСϸ°û·Î°©¡¢×ªÒÆÐÔÈéÏÙ°©¡¢³ÉЧÖÊϸ°ûÁö¡¢×ªÒÆÐÔÉö°© Rituxan Maker: Roche/Genentech Sales Rank: 8 Technology: Monoclonal antibody 2009 Sales: $5.6 billion Indications: Non-Hodgkin's lymphoma, Chronic Lymhocytic leukemia, Rheumatoid arthritis ÃÀÂÞ»ª£¨ÀûÍ×Îôµ¥¿¹£© Éú²úÉÌ£ºÂÞÊÏ/»ùÒòÌ©¿Ë ÏúÊÛÅÅÃû£º8 ¼¼Êõ£ºµ¥¿Ë¡¿¹Ìå 2009ÄêÏúÊ۶56ÒÚÃÀÔª ÊÊÓ¦Ö¢£º·ÇºÎ½Ü½ðÁܰÍÁö¡¢ÂýÐÔÁܰÍϸ°û°×Ѫ²¡¡¢·çʪÐԹؽÚÑ× Humira Maker: Abbott Pharmaceuticals Sales Rank: 9 Technology: Monoclonal antibody 2009 Sales: $5.5 billion Indications: Rheumatoid arthritis, Polyarticular juvenile idiopathic arthritis, Psoriatic arthritis, Ankylosing spondylitis (AS) in adults, Crohn's disease, Plaque psoriasis Humira£¨°¢´ïľµ¥¿¹£© Éú²úÉÌ£ºÑÅÅà ÏúÊÛÅÅÃû£º9 ¼¼Êõ£ºµ¥¿Ë¡¿¹Ìå 2009ÄêÏúÊ۶55ÒÚÃÀÔª ÊÊÓ¦Ö¢£º·çʪÐԹؽÚÑס¢Ó×ÄêÌØ·¢ÐԹؽÚÑס¢ÒøÐ¼²¡¹Ø½ÚÑס¢³ÉÈËǿֱÐÔ¼¹ÖùÑ×£¨AS£©¡¢¿ËÂÞ¶÷²¡¡¢°ß¿é×´ÒøÐ¼²¡ Seroquel Maker: AstraZeneca Sales Rank: 10 Technology: Small molecule 2009 Sales: $5.1 billion Indications: Major depressive disorder, Acute depressive episodes in bipolar disorder, Acute manic or mixed episodes in bipolar disorder alone or with lithium or divalproex; Long-term treatment of bipolar disorder with lithium or divalproex, and Schizophrenia ˼È𿵣¨¸»ÂíËáàÁòƽ£© Éú²úÉÌ£º°¢Ë¹Àû¿µ ÏúÊÛÅÅÃû£º10 ¼¼Êõ£ºÐ¡·Ö×ÓÒ©Îï 2009ÄêÏúÊ۶51ÒÚ ÊÊÓ¦Ö¢£ºÓÃÓÚÖØÖ¢ÒÖÓôÖ¢¡¢Ë«ÏòÇé¸ÐÕϰÖеļ±ÐÔÒÖÓôÖ¢×´¡¢µ¥¶À»òºÏ²¢ï®»òË«±ûÎìËáÄÆÓÃÓÚË«ÏòÇé¸ÐÕϰÖм±ÐÔÔê¿ñ»ò»ìºÏÖ¢×´£»Óë﮼Á»òË«±ûÎìËáÄÆºÏÓÃÓÃÓÚË«ÏòÒÖÓôÕϰµÄ³¤ÆÚÖÎÁÆ¡¢ÓÃÓÚ¾«Éñ·ÖÁÑÖ¢µÄÖÎÁÆ |
» ²ÂÄãϲ»¶
Ó¢Ò»ÊýÒ»408£¬×Ü·Ö284£¬¶þÕ½Õæ³ÏÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
083000»·¾³¿ÆÑ§Ó빤³Ìµ÷¼Á£¬×Ü·Ö281
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
ʳƷ¹¤³Ìר˶һ־ԸÖк£Ñó309Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
085600²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ14È˻ظ´
Ò»Ö¾Ô¸±±»¯085600²ÄÁÏר˶275|ÓÐÎÄÕÂרÀû£üÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶
ÒѾÓÐ3È˻ظ´
²ÄÁÏ¿ÆÑ§Ó빤³Ìµ÷¼Á
ÒѾÓÐ10È˻ظ´
274Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
²»µÈ¼ä¸ô¶à´Î¸øÒ©ÁÙ´²ÊÔÑé
ÒѾÓÐ5È˻ظ´
»ª±±ÖÆÒ©³É¹¦Ñз¢ÖØ×éÈËѪ°×µ°°× ³ÉΪÊÀ½çµÚÈý¼Ò¾ß±¸²úÒµ»¯ÄÜÁ¦µÄÆóÒµ
ÒѾÓÐ12È˻ظ´
2011ÄêÊÀ½ç´óѧѧÊõÅÅÃû·¢²¼
ÒѾÓÐ6È˻ظ´
¡¾·ÖÏí¡¿99¸öÈËÉú´íÎ󣺶þÊ®¼¸Ëê±ð°ÑÊÀ½ç¿´´íÁË¡¾ÒÑËÑË÷ÎÞÖØ¸´¡¿
ÒѾÓÐ9È˻ظ´

|
лл·ÖÏí |
2Â¥2010-12-05 11:34:57
caodaoba2010
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 6 (Ó×¶ùÔ°)
- ½ð±Ò: 3397
- É¢½ð: 97
- Ìû×Ó: 489
- ÔÚÏß: 138.4Сʱ
- ³æºÅ: 1065335
- ×¢²á: 2010-07-28
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
3Â¥2010-12-05 12:50:35
wjh-86
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 24.6
- Ìû×Ó: 31
- ÔÚÏß: 14.8Сʱ
- ³æºÅ: 1187476
- ×¢²á: 2011-01-11
- רҵ: ÖÐÒ©¼ø¶¨
4Â¥2011-04-08 22:14:05
xxdxy
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1664.4
- É¢½ð: 16
- Ìû×Ó: 71
- ÔÚÏß: 100.7Сʱ
- ³æºÅ: 2373969
- ×¢²á: 2013-03-24
- רҵ: ¸ß·Ö×Ó²ÄÁÏÓë»·¾³
5Â¥2013-03-28 19:53:29














»Ø¸´´ËÂ¥